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ABSTRACT 
Different mechanisms exist in the mammalian testis to protect the germ cells from 
autoimmune attack, invading microbes, and xenobiotic induced toxicity, which would 
otherwise be deleterious to the preservation of fertility. The general aim of this thesis 
was to study these testicular defence mechanisms, including the structural building 
blocks of the blood– testis barrier (BTB), antimicrobial peptides, proinflammatory 
cytokines and ATP-binding cassette (ABC) transporter proteins.  
 
Coxsackie and Adenovirus Receptor (CAR) is a cell adhesion molecule present in tight 
junctions of epithelial cells. We found that CAR was expressed in male germ cells in 
the human, the rat and the mouse testis, with a localization corresponding to the 
acrosomal structure of the elongated spermatids as well as in mature spermatozoa. CAR 
co-localized and co-immunoprecipitated with JAM-C in the mouse testis, suggesting 
that CAR may function in germ cell differentiation and polarization, similar to JAM-C. 
 
Interleukin-18 (IL-18) is a proinflammtory cytokine that contributes to host defence in 
epithelial barrier tissues. We found that IL-18, the IL-18 receptor and the interleukin-1β 
converting enzyme (ICE) was expressed in the rat testis throughout postnatal 
development. IL-18 protein and messenger ribonucleic acid (mRNA) were mainly 
localized in meiotic and post-meiotic germ cells. Only Pro-IL-18 was detected in 
interstitial fluid and in testicular cell extracts, suggesting that IL-18 normally is in its 
non-active form in the healthy testis, but may become activated during testicular 
infection. Recombinant IL-18 stimulated spermatogonial proliferation and thus may act 
as a growth factor during patho-physiological conditions in the testis. 
 
The nuclear protein High mobility group box chromosomal protein-1 (HMGB1) does 
also have extracellular immune-functions, including cytokine stimulation and direct 
antimicrobial activity. We found that HMGB1 was expressed in the nucleus and in the 
cytoplasm of Sertoli cells in the human and rat testis. HMGB1 protein was also present 
in interstitial fluid collected from non-treated rat testis, indicating extracellular release. 
HMGB1 purified from human and rat testis demonstrated strong and direct antibacterial 
activity and thus may act as an antimicrobial peptide in the seminiferous epithelium, 
contributing to the protection of the developing germ cells against invading pathogens. 
 
The ABC transporter family is responsible for active transport of substrates across 
membranes. They are located in barrier tissues such as the BTB and the blood– brain 
barrier (BBB) and protect against uptake of xenobiotics. We found that testes from 
immature (6-day-old) rats accumulated significantly higher levels of the ABC 
transporter substrate and anticancer drug doxorubicin, compared to the testes from 16- 
and 24-day old rats. This correlated with a significantly lower level of testicular 
expression of ABC transporters compared to 16- and 24-day-old rats. Thus, lack of a 
mature ABC transporter efflux system may render the immature testis more susceptible 
to xenobiotic-induced toxicity. 
 
The studies described here support the view that the mammalian testis has evolved 
several defence mechanisms to preserve fertility. 
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1 INTRODUCTION 
 
1.1 TESTICULAR DEFENCE MECHANISMS 
Protection of developing germ cells against noxious influences has high priority in all 
species to preserve fertility. Post meiotic germ cells appear long after the maturation of 
the immune system and the establishment of self-tolerance. Thus, they express antigens 
that are regarded as non-self by the immune system. To prevent an autoimmune attack, 
the germ cells therefore need to be protected from the immune system. At the same 
time, the testis faces the challenge to prevent invasion of pathogenic microbes, which 
also would be deleterious to the developing germ cells. Moreover, the testis is (already 
during fetal development) exposed to a constantly growing mixture of environmental 
pollutants, drugs and endocrine disruptors and therefore dependent on barrier strategies 
that protects against xenobiotic induced toxicity. This thesis describes different 
mechanisms that exist in the mammalian testis to protect the germ cells from 
autoimmune attack, invading microbes and xenobiotic induced toxicity. In brief, these 
strategies encompass epithelial cell barriers, secretion of immune-regulatory and 
immune-stimulatory cytokines and antimicrobial peptides as well as the testicular 
expression of ABC transporter proteins. Other protective mechanisms also exist, 
however a thorough investigation of these was beyond the scope of this thesis.  
 
1.2 CLINICAL IMPLICATIONS  
 
1.2.1 Autoimmune infertility 
Local and systemic infection and inflammation leading to disruption of the controlled 
immune balance in the testis may impair both steroid synthesis and sperm production. 
This can lead to temporary or permanent infertility. Such autoimmune infertility 
accounts for 5-10 % of male infertility cases in developed countries, but can be even 
higher in countries were investigations of reproductive health is absent (Meinhardt and 
Hedger, 2011). Orchitis (testicular inflammation) is mainly seen as a complication of 
systemic infection of paramyxovirus (mumps orchitis) or human immunodeficiency 
virus (HIV). Nevertheless, asymptomatic inflammatory reactions in the testis may also 
be an important contributor to or an underlying cause of male infertility (Schuppe et al., 
2008).  
 
1.2.2 Infertility- a late side effect of childhood cancer therapy 
Almost every day, one child in Sweden is diagnosed with cancer (approximately 300 
cases per year, according to the Swedish Children´s Cancer Foundation). Worldwide, 
the incidence is 110-130 cases per one million people per year (Bleyer, 1990). 
Previously, most children died from their cancer, but today around 75% of all children  
diagnosed with cancer will become long-term survivors (Bleyer, 1990). The positive 
development has led to the increased awareness of late side effects of childhood cancer 
therapy and the pediatric oncologists today face the challenge to keep the high survival 
rates, while minimizing the risks for late sequele. One of the most common late side 
effects is infertility. 
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The developing testis is sensitive to both chemotherapy and irradiation. However, the 
risk of developing infertility due to childhood cancer therapy depends largely on the 
type of treatment and the doses that have been given (Jahnukainen and Soder, 2003). 
Chemotherapy treatment usually involves a combination of drugs that may have 
synergistic activity. Thus, it can be difficult to elucidate the specific contributions of 
each individual agent to the overall toxicity.  
 
Furthermore, it is difficult to estimate or predict testicular side effects from pre-pubertal 
chemotherapy treatment due to a lack of proper methods to detect early signs of 
cytotoxic damage to the immature testis. It is not until puberty arrives and shows 
absence of testicular growth and sperm production and elevated levels of gonadotropins 
that the toxicity is noticed (Wallace et al., 1991, Muller et al., 1988). Moreover, the 
lack of studies investigating the maturational development of xenobiotic defence 
mechanisms, such as the testicular expression of ABC transporter proteins in pre-
pubertal boys may contribute to the above problems. 
 
In contrast to the rodent testis, there are no studies in humans demonstrating that 
treatment with cytotoxic drugs during the prepubertal period would result in more 
severe gonadal damage than treatment after puberty. In fact, the gonadal damage 
caused by doxorubicin as well as several other drugs appears to be less pronounced in 
humans than in rodents.  
 
 
1.3 THE POSTNATAL TESTIS 
A proper development of the testis is thought to be required for the determination of 
testicular size and for creating the germ line stem cell pool. Damage to the developing 
testis may thus have serious consequences for the function of the adult testis. Normal 
development of the postnatal testis involves both endocrine communication between 
the testis and the hypothalamic-pituitary axis as well as paracrine communication 
between the testicular cells. In the neonatal testis, the germ cells (gonocytes) are located 
in the center of the seminiferous cords, while the Sertoli cells and peritubular myoid 
cells are located at the basement membrane (Figure 1A). The interstitial tissue of the 
newborn testis contains fetal Leydig cells, lymphocytes, macrophages, blood and 
lymph vessels and nerves. 
  
During the neonatal period in the rat (postnatal day 0-6), the gonocytes, which have 
been in mitotic arrest, resume their mitotic activity. They also begin to migrate from the 
center of the seminiferous cords to the basement membrane, forming the stem cell pool 
(McGuinness and Orth, 1992). Here they differentiate further into type A 
spermatogonia. The proliferation of type A spermatogonia indicates the beginning of 
spermatogenesis. Thus in rats the neonatal period overlaps with the onset of puberty, 
but in humans there is a long delay between birth and the start of puberty.  
 
Sertoli cells divide rapidly after birth but cease their proliferation around postnatal day 
15-18 in the rat and around 11-14 years in humans, when they also start to develop tight 
junctions, the structural components of the BTB (Vitale et al., 1973, Steinberger and 
Steinberger, 1971). Follicle stimulating hormone (FSH) is an important stimulator of  
   3 
 
 
 
 
 
Figure1. Cross section of an immature, 6-day-old rat testis (A) and an adult human 
testis (B). SC= Sertoli cell, GC= gonocyte, IC= interstitial cell, PTC= peritubular 
myoid cell, SPC= spermatocyte, SP= spermatid, * = blood vessel. By David King, with 
permission. 
 
 
A 
B 
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Sertoli cell proliferation, but stimulation by locally produced cytokines and growth 
factors may also be involved in the process (Griswold et al., 1977, Petersen et al., 2002, 
Petersen et al., 2000, Petersen et al., 2004). No further proliferation occurs after this 
active period and the Sertoli cell number is considered to be constant. The number of 
the Sertoli cells is important because they determine the amount of developing germ 
cells that can be supported, and therefore also testicular size. As puberty progresses, the 
Sertoli cells elongate and stretch from the basal to the lumen of the seminiferous 
tubules, while supporting the developing germ cells located in crypts between adjacent 
Sertoli cells.  
 
Peritubular myoid cells surround the seminiferous tubules and function as structural 
support, as well as an aid in the transport of released spermatozoa. In the rat, they are 
contractile from postnatal day 15 and it is these contractions that facilitate the 
movement of tubular fluid and the transport of spermatozoa in the seminiferous tubules 
(Kormano and Hovatta, 1972). The peritubular myoid cells also participate in paracrine 
regulation of the seminiferous epithelium and cooperate with the Sertoli cells (Skinner 
et al., 1985, Tung et al., 1984). 
 
Prenatally, the fetal Leydig cells secrete testosterone and other androgens needed for 
development of internal and external genitalia. After birth, the fetal Leydig cells are 
still present in both the human and rat testis. In the rat, progenitors of the adult type 
Leydig cells start to differentiate and replace the fetal Leydig cells during the second 
week of postnatal life (Lording and De Kretser, 1972). The progenitors differentiate 
into immature Leydig cells by day 28 in the rat. These cells express high levels of 
testosterone metabolizing enzymes, resulting in relatively low testosterone production 
(Ge and Hardy, 1998). By day 56 in the rat, the immature Leydig cells have 
differentiated to adult Leydig cell, which have increased in number and size, as well in 
their capacity to produce testosterone (Bortolussi et al., 1990).  
 
Leydig cells and testicular macrophages live in close relation to each other. In addition 
to their immune functions, the testicular macrophages are also involved in paracrine 
regulation of normal testicular functions and have been shown to influence the 
secretion of testosterone by the Leydig cells (Yee and Hutson, 1985). Moreover, 
testicular macrophages decrease in size when Leydig cell function is impaired, 
suggesting a dual dependence on each other (Bergh, 1985). Testicular macrophages are 
initially found in the fetal testis around gestational day 19 in the mouse. They then 
increase in concentration in the interstitial compartment of the testis between postnatal 
days 13-20 and increase in size between postnatal days 20-47 (Hutson, 1990).  
 
 
1.4 THE ADULT TESTIS 
The adult testis has two major functions, i.e. the production of testosterone and the 
production of germ cells. The testosterone synthesis (steroidogenesis) takes place in the 
Leydig cells located in the interstitial compartment of the testis. The differentiation of 
the germ cells (spermatogenesis) takes place in the seminiferous tubules (Figure 1B). 
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The germ cells are located in “pockets” between adjacent Sertoli cells and are 
transported from the basal to the adluminal compartment as they differentiate. The 
Sertoli cells provide nutrients and physical support to the differentiating germ cells and 
also regulate the spermatogenic process by secreting factors that are important for germ 
cell maturation. Spermatogenesis can be divided in four phases including mitosis (self 
renewal of spermatogonia), meiosis (formation of spermatids), spermiogenesis 
(differentiation of spermatids to spermatozoa) and spermiation (release of the 
spermatozoa). Mitosis and the decision to enter meiosis are largely controlled by 
paracrine factors secreted from the somatic cells of the testis, while successful 
completion of meiosis is androgen-dependent. 
 
 The duration of spermatogenesis in rats and in humans is 52 and 74 days, respectively 
(Clermont and Harvey, 1965, Heller and Clermont, 1964, Amann, 2008). The germ 
cells together with the Sertoli cells are arranged in special cellular associations, known 
as stages. These cellular associations develop cyclically in time. There are 14 stages in 
the rat (Leblond and Clermont, 1952), while in humans there are only six (Clermont, 
1966). 
 
1.5 ENDOCRINE REGULATION OF THE TESTIS 
The testis is regulated by pituitary hormones, FSH and luteinizing hormone (LH). FSH 
acts on G-protein coupled receptors located on the Sertoli cells, to stimulate Sertoli cell 
proliferation during the perinatal period (Griswold, 1998, Griswold et al., 1977). In the 
adult testis, FSH has tropic functions including, among others, the regulation of 
secretion of transferrin, androgen binding protein, Müllerian inhibiting substance (MIS) 
and inhibin B. Inhibin B in turn regulates FSH via negative feedback (Jegou, 1992, 
Griswold, 1998).  
 
LH acts on G-protein coupled receptors located on the Leydig cells to stimulate their 
testosterone production. Testosterone then binds to the nuclear androgen receptor on 
Sertoli-, Leydig- and peritubular myoid cells exerting paracrine and autocrine effects. 
Germ cells lack androgen receptor expression and therefore testosterone regulates 
spermatogenesis via the Sertoli cells. Testosterone also has endocrine effects and 
regulates the production of LH through negative feedback (Figure 2). 
 
 
1.6 THE BLOOD-TESTIS BARRIER 
Spermatogenesis is a vulnerable process and protection of germ cells against noxious 
influences is thus needed, as mentioned in chapter 1.1. Part of this protection is 
mediated by the BTB that physically separates the meiotic germ cells from the blood 
circulation. The BTB is created by the Sertoli cells (Dym and Fawcett 1970, Setchell 
1980) and it divides the seminiferous epithelium into the basal and adluminal 
compartments, respectively. However, the peritubular and endothelial cells also 
contribute to the function of the barrier (Ploen and Setchell, 1992, Holash et al., 1993).  
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Figure 2. Endocrine regulation of the testis. 
 
 
 
 
 
 
Figure 3.  The BTB consists mainly of tight junctions between adjacent Sertoli cells. 
The meiotic and post meiotic germ cells are located above the BTB and are protected 
from the blood circulation. Illustration by Anna-Karin Sundström. 
 
BTB 
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The BTB segregates the post meiotic germ cells from the immune system, creates 
polarity and confers a unique environment for germ cell differentiation (Figure 3).  
It starts to form at postnatal day 15 to 18 in the rat and it is one of the tightest barriers in 
the body (Cheng et al., 2010). Everything that enters the adluminal compartment has to 
pass via the Sertoli cell. On the other hand, the BTB must also be able to dismantle 
during spermatogenesis to allow the passage of preleptotene and leptotene 
spermatocytes from the basal compartment to the adluminal compartment, where the 
meiosis can be completed. This junctional disassembly and reassembly occurs at stage 
VIII in the rat and is tightly regulated by cytokines and testosterone (Xia et al., 2005, 
Cheng et al., 2010, Li et al., 2009).  
 
1.6.1 Testicular junctions 
Cell adhesion is mediated by sub-cellular structures that can be divided into three major 
groups: anchoring-, gap- and tight junctions. The BTB consists mainly of tight 
junctions and the testis-specific type of anchoring junction known as the basal 
ectoplasmic specialization (ES), located between adjacent Sertoli cells (Wong and 
Cheng, 2005, Mruk and Cheng, 2004, Li et al., 2009). Besides tight junctions and basal 
ES, desmosome-like anchoring junctions and gap junctions are also integral 
components of the BTB. In contrast to other barriers, the tight junctions at the BTB are 
located on the basal and not the apical side of the epithelium. Different types of 
junctions between the Sertoli cells and germ cells also exist, depending on the 
maturational status of the germ cells. Desmosome-like junctions are formed between 
primary spermatocytes or round spermatids and Sertoli cells. In contrast, when the step 
8 spermatids start to elongate, the anchoring junctions are replaced by apical ES (Mruk 
and Cheng, 2004, Li et al., 2009). Basal and apical tubulobulbar complexes (TBC) are 
other junctional types specific to the testis (Mruk and Cheng, 2004, Li et al., 2009). 
 
1.6.2 Junctional proteins 
At the molecular level, the BTB is composed of integral transmembrane proteins, 
peripheral adaptor proteins, associated signaling molecules and cytoskeletal proteins 
(Wong and Cheng, 2005). The integral membrane proteins known to be present in the 
tight junctions in the testis include junctional adhesion molecules (JAMs), claudins and 
occludins (Cheng and Mruk, 2002, Xia et al., 2005). These junctional transmembrane 
proteins are linked to actin, via adaptor proteins zonula occludens (ZO) 1–3 (Cheng and 
Mruk, 2002). Modulation of these structural proteins, such as their degradation, 
internalization, dissociations-associations and recycling are the events that are involved 
in junctional restructuring and movement of the preleptotene spermatocytes across the 
BTB, as well as the release of step 19 spermatids into the lumen, which all takes place 
in spermatogenic stage VIII in the rat. Knockout studies of integral transmembrane 
proteins including nectin-2, nectin-3 and JAM-C have resulted in mice with impaired 
spermatogenesis, illustrating important functions of these proteins in germ cell 
differentiation (Mueller et al., 2003, Inagaki et al., 2006, Gliki et al., 2004).  
 
1.6.3 Coxsackie and adenovirus receptor 
CAR belongs to the same transmembrane immunoglobulin super family as the JAMs 
and necdins (Bergelson et al., 1997). It consists of a pair of immunoglobulin-like 
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domains in its extracellular region, a single transmembrane domain and a cytoplasmic 
tail (Bergelson et al., 1997). The cytoplasmic tail is highly conserved, suggesting an 
important role in the function of CAR. The C-terminal part of the cytoplasmic tail 
contains a (type 1) PDZ recognition motif, which is involved in the binding of CAR to 
several PDZ domain containing proteins (Cohen et al., 2001, Coyne et al., 2004, 
Excoffon et al., 2004). Due two alternative splicing, there are two isoforms of CAR, 
harboring distinct PDZ binding motifs (Philipson and Pettersson, 2004).  
 
CAR is a structural component of tight- and adherence junctions and is an adhesion 
molecule that is engaged in homotypic interactions with CAR molecules on 
neighboring cells (Figure 4) (Cohen et al., 2001, Honda et al., 2000). It also mediates 
heterophilic interactions with JAM-L, which is important for the migration of 
neutrophils across epithelial tight junctions (Zen et al., 2005). 
 
CAR is expressed in different tissues during embryonic development including CNS, 
liver, lung, heart, testis and skeletal muscle, among others (Nalbantoglu et al., 1999, 
Mirza et al., 2005, Tomko et al., 2000). In many tissues, the high level of CAR 
expression during embryonic development indicates that CAR may be involved in 
tissue formation. Indeed, CAR was shown to be required for heart development since 
CAR knockout mice die in utero, due to heart failure (Asher et al., 2005, Chen et al., 
2006, Dorner et al., 2005). 
 
In humans, CAR mRNA is highly expressed in the adult heart, brain and pancreas. 
Significant CAR expression was also found in the testis and in the prostate (Tomko et 
al., 1997, Bergelson et al., 1998). Another study reported CAR expression in germ cells 
and Sertoli cells in the rat testis, with a localization corresponding to the Sertoli-Sertoli 
and Sertoli-germ cell interface (Wang et al., 2007). Recently, we found that CAR was 
expressed in the acrosomal region of the mouse, rat and human spermatozoa. This will 
be discussed in detail in section 4.1. 
 
 
 
 
 
Figure 4. CAR is a structural component of tight junctions and adherence junctions and 
is engaged in homotypic interactions with CAR molecules on neighboring cells. 
 
CAR 
CAR 
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1.7 PARACRINE REGULATION OF THE TESTICULAR IMMUNE SYSTEM 
The BTB itself does not count for all the protection from autoimmune attack on the 
germ cells. Instead, the whole testis can be considered as an immune-privileged site. 
This was initially shown by prolonged survival of allo- and xenografts that had been 
transplanted into the interstitium of the rat testis and survival of ectopically transplanted 
Sertoli cells, co-transplanted with allogenic pancreatic tissue (Fijak and Meinhardt, 
2006). The immune privilege in the testis depends on multiple mechanisms including 
normal strategies for tolerance control, reduced immune activation, local 
immunosuppression and antigen specific immune-regulation (Meinhardt and Hedger, 
2011). An important contributor to the immune privilege is the testicular secretion of 
hormones, peptides and cytokines, including androgens, the immunosuppressive 
transforming growth factor beta (TGFβ) family and cytokines with complex 
immunoregulatory/immunostimulatory functions such as members of the interleukin-1 
(IL-1), macrophage migration inhibitory factor (MIF) and others (Schuppe and 
Meinhardt, 2005, Hedger and Meinhardt, 2003, Fijak and Meinhardt, 2006, Meinhardt 
and Hedger, 2011). 
 
However, it is important to understand that testicular immune privilege does not mean 
that the testis is incapable of mounting an efficient immune response when needed. 
Instead, infections of the testis appear to be less common than infections in the 
epididymis (Krieger, 1984). Since the adaptive immune response in the testis is 
suppressed, there is a need for greater reliance on the fast, evolutionally old innate 
immune response. This involves rapid mobilization of phagocytic cells, natural killer 
cells as well as the secretion of proinflammatory cytokines, antimicrobial peptides and 
interferons (Grandjean et al., 1997, Agerberth et al., 1995, Dejucq et al., 1997, 
Meinhardt and Hedger, 2011). The innate immune defence mechanisms that are 
discussed in more detail in this thesis involve mainly the testicular secretion of 
proinflammatory cytokines of the IL-1 family, as well as the testicular production of the 
antimicrobial peptide HMGB-1. 
 
1.7.1 Cytokines 
Cytokines are small signaling molecules, originally described as the hormones in the 
immune system. Later it became evident that many different cell types can secrete 
cytokines and they are involved in many different processes, such as regulation of the 
immune response, growth, differentiation and tissue remodeling. Cytokines act in an 
autocrine, paracrine or endocrine fashion in nano- to femtomolar concentrations. They 
can roughly be divided into proinflammtory and anti-inflammatory cytokines.  
Proinflammatory cytokines stimulate the immune response and promote inflammation. 
IL-1 and tumor necrosis factor alpha (TNFα) are classical proinflammatory cytokines. 
They produce fever, inflammation, tissue destruction and in some cases even shock and 
death, when administered to humans (Dinarello, 2000). Other important 
proinflammatory cytokines are IL-6, Interferon gamma (IFNγ) and IL-2. The anti-
inflammatory cytokines are immunoregulatory molecules that control the 
proinflammatory cytokine response. Interleukin -1 receptor antagonist (IL-1ra), IL-4, 
IL-6, IL-10 among others, belong to this group (Opal and DePalo, 2000). A 
homeostatic balance of pro- and anti- inflammatory
 
cytokines is important for the 
maintenance of
 
health. 
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1.7.2 Interleukin-18 and the interleukin-1 family of cytokines 
IL-1 is a potent proinflammatory cytokine and has several functions that are important 
for the innate immune defence (Dinarello, 2009, Dinarello, 2006). The IL-1 family 
consists of the agonists IL-1α and IL-1β and the antagonist IL-1ra. There are two IL-1 
receptors described, IL-1RI and IL-1RII, where the IL-RI is the signaling receptor and 
IL-RII act as a scavenger receptor (O'Neill, 2008, Colotta et al., 1993). IL-18 also 
belongs to the IL-1 family of cytokines and even though it has structural similarities to 
IL-1β, it signals through its own receptor, IL-18R (Nakamura et al., 1989, Parnet et al., 
1996, Born et al., 1998). There is also a naturally occurring antagonist to IL-18, the IL-
18 binding protein (IL-18BP) (Novick et al., 1999). The IL-1 family is constantly 
growing and several new members have been described (Dinarello, 2009). 
 
The IL-1RI and the IL-18R are members of the IL-1RI/Toll-like receptor (TLR) family 
(O'Neill, 2008). Upon ligand binding the receptor-ligand complex recruits a coreceptor, 
the IL-1 receptor accessory protein (IL-1RAcP) and the IL-18 receptor accessory 
protein (IL-18RAcP), respectively (Kim et al., 2001, Born et al., 1998, Greenfeder et 
al., 1995). The formation of the heterodimeric receptor is important for signal 
transduction, involving the Toll/interleukin-1 receptor (TIR) homology domains, 
recruitment of myeloid differentiation primary response gene 88 (MyD88) and IL-1 
receptor associated kinases (IRAKs) ultimately leading to activation of nuclear factor 
kappa B (NFкB) (Dunne and O'Neill, 2003, Burns et al., 1998) (Figure 5). 
 
IL-1α, IL-1β as well as IL-18 are produced as precursor proteins. The proforms of IL-
1β and IL-18 need to be processed to a mature protein before they exhibit biological 
activity, whereas IL- α has activity both as a mature and a precursor protein (Mosley et 
al., 1987). Pro-IL-1α is processed intra-cellularly by calpain, while both IL-1β and IL-
18 are cleaved by ICE (also known as caspase-1) (Black et al., 1988, Ghayur et al., 
1997, Kobayashi et al., 1990). IL-1 and IL-18 lack a signal peptide and their secretion 
does not follow the normal Golgi route. Instead, IL-1β and IL18 maturation and 
secretion requires assembly and activation of a multi-protein complex called 
inflammasome, that directs activation of ICE for cleavage of the precursor forms of IL-
1β and IL18 (Martinon et al., 2002, Martinon et al., 2009) (Figure 6). Both IL-1β and 
IL-18 can also be cleaved by proteinase 3 (Coeshott et al., 1999, Sugawara et al., 2001).  
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Figure 5. IL-18 and IL-1 signaling pathways involving binding of each ligand to their 
own receptor, interaction of the receptor with the adaptor protein MyD88, followed by 
Traf 6 and IRAK activation and finally nuclear translocation of NFкB. 
 
 
 
Figure 6. Extracellular and intracellular PAMPs bind to membrane- and intracellular 
receptors, respectively, leading to assembly of the inflammasome complex and 
activation of ICE. Pro-IL-18 is cleaved by ICE, followed by extracellular release. 
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1.7.3 The IL-1 family in the mammalian testis 
IL-1 has important functions with regard to the immune defence, but IL-1 also plays 
paracrine physiological roles in many tissues. In the testis, IL-1α is produced and 
secreted constitutively by adult rat Sertoli cells (Syed et al., 1988, Gerard et al., 1991), 
but others have also reported  IL-1α expression in germ cells (Haugen et al., 1994). The 
production of IL-1α in the Sertoli cells is dependent on interactions with germ cells 
(Jonsson et al., 1999). The expression initiates during puberty and is stage dependent 
(Soder et al., 1991, Syed et al., 1988, Wahab-Wahlgren et al., 2000). IL-1α is present 
throughout the epithelial cycle, except in stage VII, which lack mitotic and meiotic 
DNA synthesis (Jonsson et al., 1999, Wahab-Wahlgren et al., 2000). Several forms of 
IL-1α are expressed in the testis, including the 31kD proform, the 17kD mature form 
and a 24kD form that is produced from an alternatively spliced transcript (Sultana et al., 
2000). 
 
IL-1β is, in contrast to IL-1α, not produced under constitutive conditions in the rat 
testis, but the immunoreactive protein was induced in testicular macrophages, after 
systemic lipopolysacharide (LPS) treatment (Jonsson et al., 2001). In contrast, LPS 
treatment had no effect on the total level of IL-1 bioactivity in the adult testis, 
suggesting that the agonist activity of IL-1 might be regulated by IL-1ra that also was 
found to be induced in the testis by LPS treatment.  
 
There are some studies reporting IL-1ra expression in mouse Sertoli cells grown in 
vitro and immunoreactive protein has been found in Leydig cells in the human testis 
biopsies (Zeyse et al., 2000, Abu Elheija et al., 2011). However, Jonsson  
et, al did not detect constitutive expression of IL-1ra in the rat testis (Jonsson et al., 
2001). 
 
The mRNA species encoding IL-1RI and IL-1RII have been found in isolated Sertoli-, 
peritubular- and Leydig cells and testicular macrophages in the rat, mouse and human 
testis (Gomez et al., 1997). IL-1 receptors mRNAs were also found in isolated rodent 
germ cells, but not in the germ cells of the human testis. Localization of IL-1RI mRNA 
by in situ hybridization also showed a wide distribution of the receptor in the mouse, 
but not in the rat testis (Gomez et al., 1997). In addition, high affinity binding sites for 
the IL-1R has also been found to be heterogeneously distributed in the mouse testis, 
with highest density present in the luminal border of the epididymis and interstitial 
areas of the testis (Takao et al., 1990). 
 
The constitutive production of testicular IL-1α suggests that this cytokine may be 
involved in the physiological processes of the rat testis. Indeed, it has been shown that 
IL-1α stimulates germ-, peritubular- and immature Sertoli cell proliferation (Parvinen et 
al., 1991, Pollanen et al., 1989, Petersen et al., 2002, Svechnikov et al., 2004). IL-1α is 
also found in interstitial fluid (Gustafsson et al., 1988, Hedger et al., 1998), suggesting 
a paracrine role of IL-1α in the interstitial compartment. Supporting this, IL-1α has 
been shown to inhibit human chorionic gonadotropin (hCG) stimulated testosterone 
production, but to stimulate basal Leydig cell steroidogenesis (Svechnikov et al., 2001).  
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Recently, it was found that IL-1α affected the permeability of the BTB during 
spermatogenesis, suggesting a role for IL-1α in junctional dynamics (Sarkar et al., 
2008). Intratubular injection of IL-1α was shown to perturb Sertoli-germ cell adhesion 
and to compromise the integrity of the BTB. Both in vivo and in vitro studies showed 
that IL-1α treatment led to F-actin reorganization (Sarkar et al., 2008, Lie et al., 2011). 
These results indicate that IL-1 may stimulate BTB disassembly by inducing actin 
remodeling, thereby facilitate the movement of preleptotene spermatocytes across the 
BTB. 
 
1.7.4 Antimicrobial peptides 
Antimicrobial peptides have been found in plants, insects and mammalian cells and 
represent an ancient defence system.  Over 1200 antimicrobial peptides have now been 
identified or predicted from various organisms (Nakatsuji and Gallo, 2012). Many of 
the antimicrobial peptides share common features with positively charged and 
hydrophobic/amphipathic structure. This amphiphatic structure is believed to facilitate 
interactions with negatively charged phospholipids and hydrophobic fatty acids located 
in the microbial membranes, resulting in pore formation. The expression of 
antimicrobial peptides can be stimulated by TLR signaling and release of 
proinflammatory cytokines (Lai and Gallo, 2009). Antimicrobial peptides also 
contribute to host defence by influencing cytokine release, chemotaxis and antigen 
presentation (Lai and Gallo, 2009).  
 
The antimicrobial peptides can be divided in three different groups, including peptides 
with α-helical structure, cysteine-containing peptides with β-sheeted structure, 
stabilized with disulfide bonds and peptides with extended loop structure (Lai and 
Gallo, 2009). The two most studied mammalian gene families of antimicrobial peptides 
are the cathelicidins and defensins. Cathelicidins have been described in both 
invertebrates and mammals, but only one human cathelicidins gene has been found. 
This gene encodes an 18 kD precursor-protein, named hCAP18 (Lai and Gallo, 2009). 
hCAP18 is stored in granules in neutrophils. During neutrophil activation, hCAP18 is 
cleaved and released as an antimicrobial peptide of 37 amino acids, beginning with two 
leucins and therefore named LL-37. In addition to neutrophils, LL-37 has also been 
described in the testis, epididymis, skin, and respiratory epithelium (Bals et al., 1998, 
Agerberth et al., 1995, Malm et al., 2000, Murakami et al., 2004).  
 
Several mammalian α-and β-defensins have been identified. The defensins were 
originally found in the granules of neutrophils and macrophages, but later also shown to 
be produced by keratinocytes and in epithelial cells of the respiratory, digestive and 
urinary tract (Lai and Gallo, 2009, Lehrer et al., 1993).  
 
1.7.5 Antimicrobial peptides in the testis 
Several defensins has previously been detected in the rat, mouse and human 
reproductive tract (Grandjean et al., 1997). In the rat testis, most of the defensins are 
expressed in testicular macrophages and in the Sertoli- and peritubular myoid cells. 
Spermatogonia expressed only α-defensins, meiotic cells only β-defensins and post 
meiotic cells expressed both. We have recently found testicular expression of the 
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nuclear factor HMGB1 and showed that it possesses antibacterial activity, as described 
in section 4.3 in this thesis. 
 
1.7.6 High mobility group box protein-1 
Recently, it was found that the nuclear DNA binding protein HMGB1, isolated from 
the human adenoid, possessed potent antimicrobial activity (Zetterstrom et al., 2002). 
The antimicrobial activity of HMGB1 was rapid, even compared to well known 
antimicrobial peptides and it was suggested that HMGB1 was an antibacterial peptide, 
involved in the barrier defence in the adenoid. 
 
HMGB1 is expressed in most cells and was originally described as a nuclear protein 
that bound to bent DNA and thought to be involved in gene regulation and 
recombination (Bianchi et al., 1989, Bianchi, 1988, Maher and Nathans, 1996, Murphy 
et al., 1999). Since then, several extracellular functions of HMGB1 have been found, 
including the stimulation of neurite outgrowth (Huttunen et al., 1999), promoting tumor 
invasion and metastasis (Taguchi et al., 2000), being a late mediator of endotoxin 
lethality (Wang et al., 1999a), stimulating cytokine release (Andersson et al., 2000) and 
acting as a proinflammatory cytokine itself.  
 
HMGB1 have been shown to interact with several extracellular receptors including the 
receptor for advanced glycation end products (RAGE), Toll-like receptor 2 (TLR2) and 
Toll-like receptor 4 (TLR4), thereby elucidating immune stimulatory processes (Park et 
al., 2004, Huttunen et al., 1999, Kokkola et al., 2005, Yang et al., 2010). The role of 
HMGB1 as a danger signal and a proinflammatory cytokine has on the other hand been 
questioned (Tsan, 2011). Recent data indicates that highly purified HMGB1 lack 
cytokine activity and that the immune stimulatory capacity of HMGB1 requires 
complex formation of HMGB1 and LPS or HMGB1 and other pathogen-associated 
molecular patterns (PAMPs) (Pisetsky, 2011). 
 
 
1.8 XENOBIOTIC DEFENCE MECHANISMS IN THE TESTIS 
Xenobiotics are chemicals that are found within an organism, but which are not 
normally produced there. Drugs are xenobiotics in humans because our bodies do not 
produce the drugs by itself and they are not part of our normal diet. Natural compounds 
can also be regarded as xenobiotics if they are taken up by another organism that does 
not produce the compound in question. An example of this is the uptake of natural 
human hormones by fish. Pollutants are also regarded as xenobiotics, since they are 
chemical compounds that are considered foreign or artificial to the whole biological 
system. 
 
Our bodies have evolved defence systems consisting of transporter proteins located in 
epithelial cell barriers to limit the uptake of xenobiotics to the tissues. Even though 
tight junctions in epithelial barriers are efficient in preventing the entry of large 
hydrophilic substances, they are less efficient in preventing the entry of small 
hydrophobic molecules, including xenobiotic compounds such as clinically important 
drugs, environmental pollutants, dietary toxins etc., but also endogenous (non-
xenobiotic) compounds such as hormones, peptides and lipids.  
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The role of ABC transporter proteins in pharmacokinetics and in the prevention of 
xenobiotic uptake in barrier tissue has become increasingly clear. Originally, the ABC-
transporter proteins, encoded by so called multidrug resistance (MDR) genes, gained 
interest due to their over expression in tumor tissue and their diverse substrate 
specificity, leading to the development of the phenomena MDR (Ambudkar et al., 
1999). Several MDR genes have also been found in many tissues important for drug 
extrusion and elimination as well as in barrier tissues such as the BTB and the BBB 
(Leslie et al., 2005). Even though the ABC transporter proteins play an important role 
in the protection of tissues against xenobiotic-induced toxicity, their expression may 
also hinder the delivery of clinically important cytotoxic drugs to sanctuary sites such 
as the testis and the brain, which may be a disadvantage in the treatment of leukemia, 
brain tumors and other cancers.  
 
1.8.1 ABC transporter protein family 
The ABC transporter family is a large and widely expressed protein family, responsible 
for active transport of a wide range of substrates across membranes. The substrates 
include both endogenously produced compounds including phospholipids, ions, 
peptides, steroids, polysaccharides among others (Klein et al., 1999) as well as 
xenobiotic compounds such as drugs, pesticides, flavonoids (plant derived  
antioxidants) and food toxins (Table 1).  
 
Classical ABC proteins are composed of two or three membrane spanning domains, 
consisting of several transmembrane α-helices and two hydrophilic, intracellular 
nucleotide binding domains (Leslie et al., 2005) (Figure 7). Binding of ATP 
(adenosine-tri-phosphate) at the nucleotide binding domains, followed by hydrolysis of 
ATP is required for their transport of substrates across membranes (Leslie et al., 2005). 
The ABC transporter protein family can be divided into seven subfamilies (A-G) in the 
human (Dean and Allikmets, 2001, Klein et al., 1999).  
 
The most well known ABC transporter proteins that confer drug resistance include P-
glycoprotein (P-gp) encoded by multidrug resistance gene 1, (gene symbol ABCB1, 
former MDR1), the multidrug resistance protein 1 (MRP1, gene symbol ABCC1 and the 
breast cancer resistance protein (BCRP, gene symbol ABCG2) (Leslie et al., 2005). 
These ABC transporters have some overlapping substrate specificity (Table 1). All 
three are for instance involved in transport of the clinically important anticancer drug 
doxorubicin, which was used as a xenobiotic model in paper IV in this thesis (Leslie et 
al., 2005, Schinkel and Jonker, 2003).  
 
However, even though P-gp, Mrp1 and Bcrp show substrate overlap, the mechanism 
for transport may be different. P-gp has been shown to be a primary active transporter. 
In primary active transport, substrates are transported in one direction (i.e. out of the 
cell) using hydrolysis of ATP. In contrast, Mrp1 efflux is also ATP-driven, but occurs 
through a co-transport mechanism with reduced glutathione (GSH) (Leslie et al., 2005, 
Schinkel and Jonker, 2003).  
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Table 1. Xenobiotic and endogenous substrates of P-gp, Mrp1 and Bcrp. 
 
ABCB1 (MDR1/P-gp) ABCC1 (MRP1) ABCG2 (BCRP) 
Anticancer drugs 
Anthracyclines 
(doxorubicin, 
daunorubicin, epirubicin) 
Vinca Alkaloids 
(vinblastine, vincristine) 
Epipodophyllotoxins 
(etoposide, teniposide) 
Actinomycin D 
Taxanes (paclitaxel, 
docetaxel) 
 
Anticancer drugs 
Anthracyclines 
(doxorubicin, 
daunorubicin, epirubicin) 
Vinca Alkaloids 
(vinblastine, vincristine) 
Epipodophyllotoxins 
(etoposide, teniposide) 
Camptothecins (topotecan, 
irinotecan 
Anthracenedion 
(mitoxantrone) 
Heavy metal oxyanions 
(arsenite, trivalent 
antimony) 
Flutamid (antiandrogen) 
Anticancer drugs 
Anthracyclines 
(doxorubicin, 
daunorubicin 
Anthracenedion 
(mitoxantrone) 
Campothecins 
HIV protease inhibitors 
Saquinavir 
Ritonavir 
Nelfinavir 
Lopinavir 
  
Analgesic 
Morphine 
 Asimadoline 
  
Corticoids 
Dexamethasone 
Hydrocortisone 
Corticosterone 
  
Cardiac glycosides 
Digoxin 
  
Diagnostic Dyes 
Hoechst 
Rhodamine 
  
Antibiotics 
Erythromycin 
Gramicidin 
  
Dietary/environmental 
PhIP 
Dietary/environmental 
Aflatoxin B1 
Nitrose-amine conjugates 
(NNAL-O-gluc) 
Dietary/environmental 
Flavonoids (genistein,  
flavopiridol, pheophorbide ) 
PhIP 
Pesticides 
ivermectin 
chlopyrifos  
 
Pesticides 
metholachlor-GS 
metoxychlor 
fenitrothion 
Pesticides 
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ABCB1(MDR1/P-gp ABCC1 (MRP1) ABCG2 (BCRP) 
Endogenous (non-
xenobiotic) 
Phosphatidylcholine   
 
Endogenous (non-
xenobiotic) 
LTC4 
estrone 3-sulfate 
E217βG 
sulfated bile acids 
folates  
GSH and GSH disulfide 
Oxidized glutathione 
(GSSG) 
Endogenous (non-
xenobiotic) 
folic acid 
estrone 3-sulfate 
17β-estradiol-3-sulfate 
 
Modified from (Schinkel and Jonker, 2003, Kruh and Belinsky, 2003, Leslie et al., 
2005). 
 
 
 
 
 
 
 
 
 
Figure 7. Predicted secondary structures of P-gp (A), Mrp1 (B) and Bcrp (C). MSD= 
membrane spanning domain, NBD= nucleotide binding domain, CL= cytoplasmic 
loop. With permission, E.M. Leslie et al. / Toxicology and Applied Pharmacology 204 (2005) 216–237. 
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1.8.2 P-glycoprotein 
P-gp was discovered by Juliano and Ling and is the most studied member of the ABC 
transporter protein family (Juliano and Ling, 1976). It is encoded by both Mdr1a 
(Abcb1a) and Mdr1b (Abcb1b) in rodents (Devault and Gros, 1990, Silverman et al., 
1991, Schinkel, 1997). Together the two isoforms have the same distribution as human 
P-gp and suggested to have similar physiological functions (Schinkel, 1997).  
 
It has been suggested that P-gp mediates substrate efflux by acting as either a flippase 
or a hydrophobic vacuum cleaner (Schinkel and Jonker, 2003, Higgins and Gottesman, 
1992). In the former model, the substrate first has to insert to the inner leaflet of the 
plasma membrane lipid bio-layer, before being “flipped” to the outer leaflet. In the 
latter model the substrate is directly bound by P-gp in the plasma membrane and 
extruded to the extracellular environment. 
 
P-gp is expressed in a variety of tissues with excretory/secretory functions, including 
the gastrointestinal tract, liver, kidney, pancreas and adrenals, but also in tissue barriers 
such as the placenta, BBB and the testis. (Thiebaut et al., 1987, Cordon-Cardo et al., 
1990, Leslie et al., 2005). P-gp is usually located on the luminal sides of tissue barriers 
where it provides extrusion of substrates to the blood. This expression pattern indicates 
that P-gp may play an important function in reducing the exposure of tissues to 
xenobiotic agents. Indeed, Mdr1a and Mdr1a/b knockout mice support this hypothesis 
by demonstrating reduced uptake of P-gp substrates in the brain (Schinkel et al., 1997, 
Schinkel et al., 1995, Schinkel et al., 1994). 
 
1.8.3 P-gp expression and function in the testis 
In the testis, P-gp is expressed at the luminal side of the endothelial cells of the 
capillaries. Supporting a protective role in the testicular barrier defence against 
xenobiotics, Mdr1a knockout mice accumulate more of the P-gp substrates ivermectin 
and vinblastine within the testis, compared to wild type mice (Schinkel et al., 1994). 
Mdr1a/b knockout mice also demonstrate enhanced penetration of digoxin into the 
testis. (Schinkel et al., 1997). The protective role of P-gp in the testis have also been 
demonstrated by pharmacological inhibition of P-gp, leading to increased testicular 
uptake of the HIV inhibitor nelfinavir (Choo et al., 2000).  
 
The testicular expression of P-gp is not limited to the endothelial cells, but also located 
to Leydig cells, macrophages, peritubular myoid cells, Sertoli cells and late spermatids 
(Melaine et al., 2002) (Figure 8). P-gp is not expressed in mitotic and meiotic germ 
cells, which could at least partly explain the susceptibility of these cell types to 
anticancer therapy. Recently it was shown that P-gp is an integrated component of the 
BTB, where it co-localizes with several tight junctional proteins and suggested to 
participate in the regulation of BTB dynamics (Su et al., 2009).  
 
1.8.4 Testicular expression of Mrp1 and Bcrp 
Mrp1 expression is found in several organs including the brain, kidney, placenta and 
testis (Bart et al., 2004). In the testis Mrp1 is localized to the basal side at the Sertoli 
cells and Leydig cells (Wijnholds et al., 1998). Mrp1 knockout mice are healthy and 
fertile, but etoposide treatment resulted in disrupted spermatogenesis and transient 
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infertility (Wijnholds et al., 1998). This was not seen in etoposide-treated wild type 
mice. Mrp1 have also been shown to protect the seminiferous tubules against damage 
mediated by the pesticide methoxychlor (Tribull et al., 2003). Mrp1 transports sulfated 
estrogens and the co-localization of Mrp1 and estrogen sulfotransferase in Leydig cells 
may suggest that Mrp1 is involved in maintaining the low estrogen levels in the testis 
(Leslie et al., 2005)  
 
The testicular expression of Bcrp is located in myoid cells and the luminal side of 
endothelial cells in humans (Bart et al., 2004). Bcrp limits the testicular entry of the 
phyto-estrogen genistein (Enokizono et al., 2007). Phyto-estrogens are plant 
compounds that can bind to estrogen receptors on the Leydig- and Sertoli cells, 
inducing estrogenic or anti-estrogenic effects. It has also been reported that Bcrp is 
regulated by estrogen, testosterone and progesterone (Hartz et al., 2010, Merino et al., 
2005, Tanaka et al., 2005). Bcrp itself also functions as a transporter of sulfonate-, 
GSH- or glucuronide-conjugated steroid hormones (Mao and Unadkat, 2005). Thus, 
Bcrp, similar to Mrp1, may be involved in physiological steroid transport in the testis in 
addition to its role in xenobiotic protection.  
 
 
 
 
Figure 8. Expression of P-gp in different cell layers of the testis. Endothelial cell 
expression confer efflux of xenobiotics to the blood circulation, while Sertoli cell and 
peritubular myoid cell expression leads to xenobiotic efflux from the seminiferous 
tubules, aiding in germ cell protection. P-gp expression in Leydig cells may indicate 
involvement of P-gp in steroid transport. Elongated spermatids express P-gp and may 
protect these cells from xenobiotic toxicity during epididymal maturation or in the 
female genital tract. E= endothelial cell, MQ= testicular resident macrophage, LC= 
Leydig cell, SC= Sertoli cell, PTC= peritubular myoid cell, SP= elongated spermatid. 
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2 AIMS OF THE STUDY 
 
The general aim of this work was to study defence mechanisms that contribute to the 
antimicrobial, immunological and xenobiotic protection of developing germ cells in the 
mammalian testis. 
 
The specific aims were: 
 
1. To study the expression, localization and function of CAR in the mouse, rat and 
human testis as well as to investigates its role in mature spermatozoa. 
 
2. Investigate the expression and paracrine function of IL-18 in the developing 
postnatal rat testis. 
 
3. Study the expression, localization and antimicrobial activity of HMGB-1 in the 
human and rat testis. 
 
4. To study the ontogeny of the testicular ABC transporter dependent protection 
against xenobiotic-induced toxicity of the rat testis. 
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3 MATERIALS AND METHODS 
 
3.1 ANIMAL EXPERIMENTS 
 
3.1.1 Testis donors (paper I-IV) 
Male Sprague Dawley rats in different postnatal ages (6, 10, 16, 20, 24, 30, 40 and 60-
day-old) were used as testis donors for the polymerase chain reactions (PCRs), western 
blot, in situ hybridizations, immunohistochemistry (IHC) and indirect 
immunofluorescence (IF) analyses. Testis biopsies from three men (30-40 years old) 
undergoing fertility examination, but with qualitatively and quantitatively normal 
spermatogenesis, were used for the reverse transcriptase PCR (RT-PCR) analyses in 
paper III. The testis that was used for in situ hybridization (paper III) was obtained 
from a 70-year-old man with prostate cancer and the material used for IHC was 
obtained from the healthy testis from a 33-year-old man with seminoma. 
 
3.1.2 LPS treatment of rats (paper II) 
LPS is a component of the cell wall of gram negative bacteria and induces a strong 
inflammatory response when injected to animals. To study the activation of IL-18 
under inflammatory conditions, 60-day-old male Sprague Dawley rat were treated with 
a single intraperitoneal injection (i.p.) of 50 and 100 µg/kg LPS for 6 hours, before the 
testes, liver and spleen were removed for subsequent analysis. 
 
3.1.3 Doxorubicin treatment of rats (paper IV) 
6-, 16- and 24 day-old Sprague Dawley rats were injected i.p. with 3 mg/kg of the 
anticancer drug doxorubicin. The animals were sacrificed after 5, 20 and 60 minutes, 
followed by removal of the testes for subsequent doxorubicin measurements. Rats in 
the same ages also received the same treatment for 4 hours and 24 hours, before testes 
were removed and frozen at -80 °C. 
 
3.2 ISOLATION AND IN VITRO CULTURE OF TESTICULAR CELLS 
 
3.2.1 Staging of rat seminiferous tubules (paper I and II) 
In the rat testis, an epithelial cycle can be divided in 14 stages, where each stage refers 
to a unique association of different germ cell types with the Sertoli cells (Clermont, 
1972). The different stages can be identified by the use of a transillumination 
microscope, combined with a normal light microscope and the squash preparation 
technique (Parvinen and Vanha-Perttula, 1972, Soderstrom and Parvinen, 1976). In 
brief, the testes are decapsulated and the seminiferous tubules washed in phosphate 
buffered saline, under a transillumination microscope. The different stages are 
identified on the basis of their different light absorption, which depends on the level of 
chromatin condensation in the haploid cells. This technique was employed to isolate 
two millimeter segments from spermatogenic stages I, V, VIIa and VIII-IX, followed 
by in vitro culture for 24, 48 and 72 hours and subsequent proliferation analyses.  
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Half millimeter segments of seminiferous tubules were also squashed carefully against 
a cover slip, snap frozen and fixed for subsequent immunohistochemical analyses to be 
able to identify germ cells in the different developmental phases.  
 
3.2.2 Isolation of mouse and human spermatozoa (paper I) 
Several mouse epididymides were pooled, cut into small pieces in PBS and 
spermatozoa were isolated by filtration. The cell suspension was centrifuged to pellet 
the cells. Human spermatozoa were donated from patients at the fertility unit in the 
Karolinska University Hospital, Sweden. The spermatozoa were separated by the swim 
up technique. This method utilizes the motility of spermatozoa to separate them from 
seminal fluid. In brief, the semen is overlaid by pre-equilibrated culture medium in a 
culture tube, incubated for 40-60 min where after the sperm is collected from the top 
milliliter, washed and pelleted by centrifugation.  
 
3.2.3 In vitro induction of the acrosomal reaction (paper I) 
During fertilization the sperm must penetrate the hard shell of the egg. In order to do so 
the sperm goes through an acrosomal reaction. During this event, the membrane of the 
acrosome (the cap structure of the sperm) fuses to the zona pellucida, releasing its 
acrosomal contents.  The acrosome reaction can also be stimulated in vitro by the 
calcium ionophore A23187. We employed this to induce the acrosome reaction in 
purified human spermatozoa, followed by centrifugation and washing of the cell pellet, 
that was subjected to IF omitting the fixation and permeabilization step. 
 
3.2.4 Isolation and in vitro culture of Leydig cells (paper II) 
Leydig cells were isolated from 40-day-old rats, using a two step purification method 
that yields 90 % purity and viability (Svechnikov et al., 2001). These cell cultures were 
incubated in the presence or absence of different concentrations of recombinant rat IL-
18, with or without hCG. The testosterone concentration in the culture supernatant was 
then measured by radioimmunoassay (RIA). Leydig cells from 20-day-old rats were 
also isolated and cultured in vitro for subsequent proliferation analyses. In contrast to 
cell-lines, primary cultures of Leydig cells exhibit native steroidogenic activities and 
thus give reliable results regarding the intracellular functions of mammalian Leydig 
cells.  
 
 
3.3 METHODS TO STUDY APOPTOSIS 
 
3.3.1 Cell death ELISA (paper II) 
The ELISA kit for detection of cell death was used for the detection of apoptosis in cell 
lysates from stage I segments of seminiferous tubules after incubation with or without 
IL-18. The cell death ELISA allows for rapid quantification of histone-complexed 
DNA fragments which are released from apoptotic or necrotic cells.  
 
3.3.2 In situ 3’ end (TUNEL) labeling (paper II) 
Terminal deoxynucleotidyl transferase (TdT) is a DNA polymerase that adds 
nucleotides to the 3’ end of gene segments without the use of a template strand. It is 
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therefore used for the biotin-labeling of blunt ends of fragmented double stranded DNA 
found in apoptotic cells. This method was used to quantify apoptosis of spermatogonia 
in stage I segments of seminiferous tubules after incubation with or without 
recombinant IL-18.  
 
3.3.3 Cleaved caspase 3 (paper II) 
Another marker of apoptosis is the presence of the cleaved or activated form of the 
apoptosis executor protein caspase-3, which can be detected by specific antibodies and 
used to visualize apoptotic cells in fixed tissue preparations. This method was used in 
combination with in situ 3’ end labeling and cell death ELISA to determine possible 
anti-apoptotic effects of IL-18 on differentiating spermatogonia.   
 
3.4 METHODS TO STUDY GENE EXPRESSION 
 
3.4.1 Reverse transcriptase PCR (paper I, II & III) 
RT-PCR was employed for the detection of CAR, IL-18 and HMGB1 mRNA 
expression in tissue extracts from mouse, rat and human testes. In brief, the RNA is 
extracted and reversed transcribed into cDNA (complementary deoxyribonucleic acid) 
using the enzyme reverse transcriptase, followed by amplification of the cDNA by 
PCR. This requires the use of gene specific primers that binds to the specific cDNA, 
allowing the Taq polymerase chain reaction to occur. The PCR products are then 
visualized by agarose gel chromatography followed by ethidium bromide staining. In 
contrast to real-time PCR, conventional RT-PCR measures the endpoint of the PCR 
reaction and can only be used in a semi-quantitative way due to saturation effects etc.  
 
3.4.2 Real-time PCR (paper IV) 
Real-time PCR was used to quantify the developmental expression of ABC transporters 
in the postnatal rat testis. This method is based on RT- PCR combined with the use of 
fluorophores, which allows for the direct measurement of the DNA amplification 
instead of the end point. During each cycle, the dye SYBR green incorporates to the 
cDNA and cause an increase in fluorescent intensity that can be measured “in real 
time” and thus used for accurate quantification of gene expression. The limitation of 
using CYBR green as a flourophore is that it binds to any double stranded DNA, 
including primer dimers or nonspecific PCR products and this may interfere with the 
results. 
 
3.4.3 S35 In situ hybridization (paper II & III) 
S
35 
In situ hybridization was employed to localize the expression of IL-18 and 
HMGB1 transcripts in testicular tissue. This method utilizes S
35
-labeled 
oligonucleotide DNA probes that are complementary to the target mRNA of interest. 
After hybridization of the radioactive probe to the tissue, the tissue sections are 
washed, dipped into film emulsion, exposed and developed. The positive cells are 
identified using dark and bright field microscopy. In contrast to PCR, in situ 
hybridization allows for the cellular localization of gene expression in tissues.  
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3.5 METHODS TO STUDY PROTEIN EXPRESSION AND INTERACTIONS 
 
3.5.1 Western blot analysis (paper I, II & III) 
The presence of CAR, IL-18 and HMGB1 protein in testicular tissue extracts was 
studied by western blot. Western blot was also employed for detection of multiple 
forms of the proteins, such as activated IL-18 that are processed by cleavage.  
The total cell protein concentration was measured by Bradford and subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by transfer 
and incubation of the membrane by specific antibodies against the protein of interest.  
 
3.5.2 Immunohistochemistry & Immunofluorescence (paper I, II, III & IV) 
We performed IHC or IF to study the localization of CAR, IL-18, HMGB1 and P-gp in 
the mammalian testis. In both methods antibodies are utilized to identify and localize 
proteins in tissue sections. The major difference between the two methods is that in 
IHC the primary protein-antibody complex is bound to a biotin-conjugated secondary 
antibody and thereafter amplified by a biotin-streptavidin step, followed by a color 
reaction, most commonly 3,3-Diaminobenzidine (DAB). In IF the primary protein-
antibody complex is detected by a secondary antibody conjugated with a fluorescent 
dye. IF was also used to study the co-localization of P-gp with the junctional proteins 
ZO-1 and occludin, employing two secondary antibodies with different fluorophores. 
Addition of an antigen-retrieval step to the IHC/IF protocol was done in some cases to 
prevent false negative results due to fixation-induced masking of epitopes in the tissues.  
 
3.5.3 GST pull-down assay (paper I) 
Glutathione S- transferase (GST) -fusion proteins can be constructed to investigate 
direct protein-to-protein interactions in a GST-pull down assay. Following binding of 
potential binding partners to the GST-fusion protein, the GST-complex is bound to 
GSH-coated beads. The interacting proteins may then be identified using specific 
antibodies. In order to isolate CAR from mouse testis, two GST constructs of the p70 
and p80 ligand of numb (LNX) protein isoforms were used as baits. The GST-LNX 
fusion proteins were incubated with testicular homogenates and bound proteins were 
separated on SDS-PAGE, transferred to filters and analyzed by western blot, using 
antibodies against CAR.  
 
3.5.4 Co-immunoprecipitation (paper I) 
Co-immunoprecipitation of was performed to investigate if CAR and JAM-C could 
form a protein complex in vivo. Proteins in mouse testicular homogenates were 
precipitated employing an anti JAM-C antibody and separated by SDS-PAGE, 
followed by transfer and Western blot. Coprecipitated CAR protein was visualized by 
the specific CAR antibody RP1284. 
 
3.6 H3-THYMIDINE INCORPORATION (PAPER II) 
Spermatogonial, as well as Leydig cell DNA synthesis was measured by H
3
-thymidine 
incorporation. Two mm segments of seminiferous tubules in defined stages and isolated 
Leydig cell were cultured in vitro for 24 and 48 hours. Four hours before harvest, the 
cells were pulsed with 0.5 µCi H
3
-thymidine, which is incorporated into the DNA of 
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dividing cells. Incorporated radioactivity (counts per minutes, cpm) was measured in a 
β-scintillation spectrometer. The limitation of this method is that measuring thymidine 
incorporation does not exclusively give a value of DNA replication, but also measures 
DNA repair.  
 
3.7 RADIOIMMUNO ASSAY (PAPER II) 
RIA was used for the determination of the testosterone production by Leydig cells after 
exposure to IL-18. This method measures hormone concentrations in cell culture media 
and in blood. It is based on the competitive antibody binding of radio-labeled hormone 
and the hormone present in the sample. 
 
3.8 REVERSED PHASE HPLC (PAPER III &IV) 
Reversed phase high performance liquid chromatography (HPLC) is a method used to 
separate and purify proteins as well as other molecules in tissue or blood samples. The 
stationary phase contains lipophilic groups. When the sample is passed through the 
system the lipophilic proteins/molecules will remain in the column, while the 
hydrophilic proteins will be eluted. Reversed phase HPLC was employed to purify and 
isolate peptides with antibacterial activity from testicular extracts (paper III) and for the 
determination of the doxorubicin concentrations in testicular tissue extracts after in vivo 
treatment (paper IV). 
 
3.9 ZONE INHIBITION ASSAY (PAPER III) 
The inhibition zone assay is an antibacterial assay and was employed for determination 
of the antibacterial activities in the HMGB1 positive and negative fractions obtained by 
the reversed phase HPLC. Small wells are punched out in an agar plate and seeded with 
a bacterial strain. The sample to be tested is added to the well and incubated for 
appropriate time. The diameters of the inhibition zones are then measured as reflections 
of the ability of the test substance to kill the bacteria. 
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4 RESULTS AND DISCUSSION 
 
4.1 CAR IS EXPRESSED IN MALE GERM CELLS  
Several junctional proteins of the CTX (cortical thymocyte xenopus) family are 
expressed in the mammalian testis and play important roles in spermatogenesis. 
Targeted deletion of JAM-C revealed an important role of this CTX protein in creating 
polarity in round spermatids (Gliki et al., 2004). Other adhesion molecules such as 
nectin-2 and 3 have also been shown to be important for spermatogenesis (Mueller et 
al., 2003, Inagaki et al., 2006).We therefore wanted to investigate the testicular 
expression and localization of the CTX member CAR. Endpoint RT-PCR of total RNA 
isolated from mouse testis, as well as western blot and GST-pull down experiments 
from mouse testis homogenates showed expression of CAR at the mRNA and protein 
level. IF localized CAR protein to the lumen of the seminiferous tubules in cells 
corresponding to elongating spermatids. The CAR staining was sickle shaped and in 
close association with the condensed nuclei, indicating acrosomal localization. Weak 
CAR staining was also observed in more immature germ cells. Indirect 
immunofluorescent staining of CAR in staged segments of rat seminiferous tubules 
demonstrated CAR expression in round spermatids and in late stages of elongated 
spermatids, most pronounced in stage VIII. 
 
A previous study, using the Rmcb antibody on sections from mouse testis, showed a 
different CAR expression pattern than what we found (Peters et al., 2001). In this study, 
CAR was found in all germ cell types, as well as in Leydig- and Sertoli cells. However, 
in our hands we failed to detect mouse CAR with the Rmcb antibody. Our results are 
mainly in agreement with the later study by Wang et al (Wang et al., 2007), showing 
strong CAR expression on the convex side of the elongate spermatid head in stage VIII 
of the rat testis. Wang et al, also demonstrated CAR expression in round spermatids 
and, in contrast to us, in the BTB of the Sertoli cells. The discrepancies may be due to 
the use of different antibodies and immune-protocols, or by the fact that we performed 
testicular CAR-localization studies on mouse tissue. Another study by our laboratory 
confirmed the absence of CAR in the tight junctions of the Sertoli cells (Mirza et al., 
2007). 
 
At spermiation, the stage VIII spermatozoa are released and transported to the 
epididymis for further maturation. The presence of CAR in late spermatids in stage VIII 
prompted us to look for CAR in released spermatozoa. We found that CAR co-
localized with the acrosomal marker peanut agglutinin (PNA) in spermatozoa isolated 
from mouse epididymis. Using isoform specific antibodies we found that CAR-1 was 
expressed all over the acrosome, while CAR-2 was restricted to the inner acrosomal 
membrane, suggesting that the two different CAR isoforms may have different 
functions.  
 
Many spermatozoa isolated from epididymis are not fully mature and fertilization 
competent. Therefore, we wanted to investigate CAR expression in mature 
spermatozoa, isolated from human ejaculates. CAR was found to be co-expressed with 
PNA in the acrosome of mature human spermatozoa.  
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During fertilization, the sperm binds to the zona pellucida, followed by an acrosomal 
reaction involving fusion of the outer acrosomal membrane and the plasma membrane, 
release of acrosomal enzymes and exposure of the inner acrosomal membrane. The 
acrosomal reaction is needed for the sperm to be able to penetrate the zona pellucida. 
The proteins of the inner acrosomal membrane then adheres to the plasma membrane of 
the oocyte (Kaji and Kudo, 2004). To see whether CAR could be exposed to the surface 
of acromsome-reacted sperms, an acrosome reaction was induced in vitro, followed by 
IF staining of the immunoglobulin domains of CAR. We found that CAR was exposed 
to the surface of acrosome-reacted but not acrosome-intact sperms, indicating that CAR 
may be involved in the events following the acrosome reaction such as passage through 
the zona pellucida or interaction with the egg plasma membrane. 
 
CAR has been shown to interact with the two cytoplasmic proteins LNX and LNX2. 
These are PDZ-domain containing scaffolding proteins involved in protein– protein 
interactions (Rice et al., 2001). We found acrosomal localization of LNX2, while LNX 
was located in a structure called acroplaxome, located below the acrosome. The role of 
these two proteins in spermatozoa and their interaction with CAR needs further 
investigation. 
 
Our finding that CAR co-localized and co-immunoprecipitated with JAM-C in the 
mouse testis, suggests that the two proteins interact in vivo. JAM-C is expressed in the 
junctional plaques that anchor the spermatids to the Sertoli cells, which is necessary for 
germ cell differentiation (Gliki et al., 2004). Similar to CAR, we also found that JAM-
C is localized to the acrosome in isolated spermatozoa. Round spermatids from JAM-C 
deficient mice lack acrosomal structures and lack all morphological signs of polarity. 
No further differentiation, such as condensation of nuclei and formation of flagella, 
occurs in these mice, leading to infertility. It might be that CAR also is involved in 
germ cell differentiation and polarization. Since CAR deficient mice die in utero, 
conditional knock outs need to be done to investigate the role of CAR in 
spermatogenesis. 
 
The acrosomal membrane and the plasma membrane are in close connection in 
elongated spermatids and therefore it is difficult to rule out the exact spermatid 
localization of CAR by IF. Co-localization of CAR and the cytoplasmic specialization 
marker Espin, as well as localization of CAR to spermatogonia, lacking acrosomes, 
suggest that CAR localizes to the plasma membrane (Wang et al., 2007). We found that 
CAR co-localizes with the acrosomal marker PNA in human and mouse spermatozoa, 
suggesting that CAR is a multifunctional protein localized to the germ cell plasma 
membrane at spermatid-Sertoli cell junctions, mediating spermatid-Sertoli cell adhesion 
or migration of spermatocytes across the BTB (Mirza et al., 2007, Wang et al., 2007), 
but also expressed in the acrosome in mature spermatozoa, playing a role in the 
fertilization of the oocyte.  
 
CAR expression in endothelial cells is down-regulated by the inflammatory cytokines 
IFNγ and TNFα (Vincent et al., 2004). A down-regulation of CAR protein expression 
in Sertoli cells was also seen after TNFα treatment in vitro (Wang et al., 2007). 
Cytokine-mediated down-regulation of CAR may have implications for germ cell–
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Sertoli cell adhesion and germ cell differentiation during patho-physiological 
conditions in the testis, such as testicular inflammation. 
 
4.2 EXPRESSION OF INTERLEUKIN-18 IS IN THE RAT TESTIS 
The expression of cytokines and antibacterial peptides in the testis may reflect local 
host defence mechanisms with the functions to protect developing germ cells from 
harmful effects of infections. The IL-1 system in the testis has previously been studied 
(for review see Svechnikov et, al. (Svechnikov et al., 2004)). Since IL-18 is a relatively 
new member of the IL-1 family, we wanted to investigate the expression and paracrine 
function of this proinflammatory cytokine in the rat testis.  
 
We found that IL-18 mRNA is expressed in a constitutive manner during postnatal 
testicular development in the rat, as well as in the adult rat testis. Constitutive mRNA 
expression of IL-18R and ICE was also found in the developing and adult rat testis. The 
expression of IL-18 and IL8R showed no signs of stage dependency by RT-analyses of 
pooled segments of staged seminiferous tubules. Although a slight decrease in the 
mRNA species encoding ICE was observed in stage XIV-VI. Western blot analysis of 
rat testicular extracts from different postnatal ages revealed constitutive production of 
the immature (24 kD) form, but not the processed (18 kD) form of IL-18. Treatment of 
60-day-old rats with 50 or 100 µg/kg LPS, a treatment that is known to induce IL-1β 
expression in the rat testis, failed to induce processing of pro-IL-18 (Jonsson et al., 
2001). In situ hybridization and IF analysis showed that the IL-18 mRNA expression 
was localized to spermatocytes and round spermatids, while the most prominent site for 
the IL-18 protein expression was the round and elongating spermatids. 
 
Our data on testicular IL-18 expression differ from a later study by Elhija et, al. (Abu 
Elhija et al., 2008), in which IL-18, IL-18R and ICE was found to be expressed at 
higher levels in sexually immature mice, compared to adult mice. In this study, 
constitutive production of the cleaved form of IL-18 was found, both in immature and 
adult testes. In contrast to our results, IL-18 was localized to the spermatogonia and the 
interstitial cells. The underlying reason for these discrepancies is not clear, but could be 
due to different species, antibodies and protocols used. 
 
Processing of proIL-18 requires cleavage by active ICE (Ghayur et al., 1997). We 
found abundant testicular mRNA expression of this enzyme. However, we did not 
investigate the presence of active ICE protein in the rat testis. Active ICE was indeed 
found in the mouse testis (Abu Elheija et al., 2011). Activation of ICE requires the 
assembly of a multiprotein complex called inflammasome (Martinon et al., 2002). At 
least three types of inflammasomes have been identified, consisting of ICE and 
different members of the NOD-like receptor family (NLR) (Martinon and Tschopp, 
2005). This protein family acts as sensors for bacterial components or danger signals, 
triggering an innate immune response, similar to TLRs. The NLR-family member 
Nacht- LRR-PYD containing protein 1 (NALP-1) has been found in spermatogonia and 
round spermatids in the human testis (Kummer et al., 2007), suggesting that the testis 
may have the capacity to process ICE, leading to IL-18 activation, in response to 
invading pathogens.  
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IL-18 has been shown to stimulate growth of chondrocytes and osteoblasts (Cornish et 
al., 2003). We also found that recombinant rat IL-18 stimulates spermatogonial DNA 
synthesis in stage I segments of seminiferous tubules cultured in vitro, suggesting a 
paracrine, growth promoting role for IL-18 in the testis. Similar to IL-18, IL-1α has 
been shown to stimulate spermatogonial DNA synthesis (Parvinen et al., 1991). In 
contrast to IL-18, IL-1α shows a stage dependent expression pattern that mimics the 
DNA synthesis pattern (Soder et al., 1991). No effect of IL-18 on the level of apoptosis 
in cultured stage I segments of seminiferous tubules was observed, indicating that the 
enhanced DNA synthesis in response to IL-18, did not reflect a decrease in apoptotic 
activity.  
 
Western blot analysis revealed the presence of proIL-18 in interstitial fluid, which may 
reflect secretion of IL-18 into this compartment. On the other hand, since we detected 
IL-18 protein production in spermatids which are located behind the BTB, a secretion 
of IL-18 to interstitium is difficult to explain, but could be a consequence of the 
incompleteness of the BTB at the rete testis. In addition, IL-18 may also be secreted by 
interstitial cells. Indeed, we found expression of IL-18, as well as IL-18R and IL-
18AcPL mRNA species in isolated Leydig cells cultured in vitro, which may indicate a 
role for IL-18 in paracrine or autocrine Leydig cell regulation. However, positive RT-
PCR results obtained from in vitro cultured cells should always be interpreted with 
caution, since cell isolation and in vitro culture may induce expression of cytokines and 
receptors. We could not detect any significant effect of IL-18 on testosterone synthesis 
in immature Leydig cells, either in the presence or absence of hCG, albeit we saw a 
weak but non-significant stimulation of basal testosterone production. Neither did IL-
18 stimulate Leydig cell proliferation as measured by thymidine incorporation. In 
contrast to IL-18, IL-1α and IL-1β have been shown to regulate Leydig cell 
steroidogenesis, as well as proliferation of immature Leydig cells in vitro (Svechnikov 
et al., 2001, Svechnikov et al., 2004, Khan et al., 1992).  
 
Taken together, our findings show a constitutive production of proIL-18, as well as 
expression of ICE and IL-R in the immature and adult rat testis and the localization of 
IL-18 production to the meiotic and post-meiotic germ cells. In addition, we found that 
IL-18 could stimulate germ cell proliferation in vitro. Considering the innate immune-
functions of IL-18 and the presence of only the pro-form of IL-18 in the testis, we 
suggest that IL-18 activity in the testis is tightly controlled to prevent harmful effects of 
inflammatory reactions. At the same time, upon invasion of pathogens, the testis is 
likely to mount an efficient innate immune response resulting in activation of ICE and 
IL-18. Therefore, we suggest that IL-18 may act as a mitogenic factor for germ cells 
during patho-physiological conditions. Further studies regarding the danger- or 
pathogen signals that trigger ICE activation in the testis and the following IL-18 
response to this will be necessary in order to understand the testicular role and 
regulation of IL-18.  
 
IL-18 is not a requirement for fertility under physiological conditions, since IL-18 
knockout mice produce offspring at the predicted mendelian ratio (Takeda et al., 1998). 
Nevertheless, challenging these IL-18 deficient mice with systemic or uro-genital 
infection may give clues to the patho-physiological role of IL-18 in testis. 
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4.3  HMGB1 1 IS EXPRESSED IN THE TESTIS WHERE IT MAY 
FUNCTION AS AN ANTIBACTERIAL FACTOR 
 
Previous studies in our laboratory have shown that the DNA-binding, nuclear protein 
HMGB1, isolated from the adenoid, possesses potent antibacterial activity comparable 
to that of classical antimicrobial peptides (Zetterstrom et al., 2002). It was therefore 
suggested that HMGB1 is playing a role in the innate immune defence against invading 
microbes in the adenoid. Since the testis is an important barrier tissue designed to 
protect the germ cells from harmful influences, we wanted to investigate the expression 
and antibacterial functions of HMGB1 in the rat and human testis. 
 
RT-PCR analyses revealed expression of HMGB1 mRNA in adult human and rat testis, 
as well as in immature rat testis. The mRNA expression was localized to the Sertoli 
cells and possible also germ cells in the adult human and rat testis as shown by in situ 
hybridization. In the testes from 10-day-old rats, HMGB1-transcripts were observed in 
the central portion of the seminiferous tubules, corresponding to the localizations of 
immature Sertoli cells at this age. IF staining of rat and human tissues showed a similar 
localization of HMGB1 protein in Sertoli cells as well as in immature germ cells. 
Moreover, we also found expression of HMGB1 in interstitial cells, peritubular myoid 
cells and endothelial cells. The cellular localization was mainly nuclear for all cell 
types except for the Sertoli cells were HMGB1 also was found in the cytoplasm. In 
some of the interstitial cells, HMGB1 co-localized with the testicular macrophage 
marker ED2. 
 
Our results are in line with a previous study, showing the presence of HMGB1 both in 
the nuclear and cytosolic fractions of homogenized testis tissue (Mosevitsky et al., 
1989). Since the first discovery of HMGB1 as a nuclear protein, several extracellular 
functions of HMGB1 have been found, including the stimulation of inflammatory 
responses and tissue repair (Wang et al., 2004, Wang et al., 1999a, Andersson et al., 
2000). The sub-cellular localization of HMGB1 in monocytes is dependent on the 
acetylation status of the nuclear localization signal of the HMGB1 protein (Bonaldi et 
al., 2003). Upon inflammatory stimulation, HMGB1 becomes hyper-acetylated and re-
locates to the cytoplasm, where it, followed a second stimulus, is released extra-
cellularly (Gardella et al., 2002). Other studies have shown that also phosphorylation of 
HMGB1 is important for its cytoplasmic localization (Oh et al., 2009, Youn and Shin, 
2006). Whether similar mechanisms determines sub-cellular localization of HMGB1 in 
Sertoli cells remains to be investigated. There are indeed many similarities between 
Sertoli cells and macrophages, including the ability to phagocytose and produce 
defensins (Grandjean et al., 1997). 
 
We found HMGB1 protein to be present in interstitial fluid collected from non-treated 
rat testes, indicating extracellular release. HMGB1 can be released to the extracellular 
milieu passively by necrotic cells or actively by immune cells, where it is believed to 
act as a danger signal, warning for tissue injury or invading pathogens (Andersson et 
al., 2002, Yang et al., 2007). Interestingly, inflammasomes, the large multi-protein 
complexes involved in ICE activation and subsequent release of IL-1β and IL-18 were 
recently shown to mediate extracellular release of also HMGB1 (Vande Walle et al., 
2011). In addition to immune cells, it has been shown that viable, non-immune cells 
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can secrete HMGB1 in response to cytokine or LPS stimulation (Xu et al., 2010, Liu et 
al., 2006, Wang et al., 1999b). Whether the presence of HMGB1 in testicular interstitial 
fluid is due to passive leakage or active secretion needs further investigation.  
 
We demonstrated that HMGB1 purified from the human and rat testis possessed strong 
antimicrobial activity in antibacterial assays, suggesting that HMGB1, similar to LL-37 
and the defensins, is part of a surveillance system designed to protect the testis against 
bacterial infections. The presence of innate defence mechanisms based on testicular 
production of antimicrobial peptides may explain the relative rareness of testicular 
infection, compared to the rest of the urogenital tract. Because HMGB1 has been 
proposed to posses extracellular immune-stimulatory functions we speculate that the 
production of HMGB1 in Sertoli cells serves dual tasks, that is to directly kill invading 
microbes and to act as a co-stimulator of the immune-response. Considering the potent 
immune-stimulatory properties of HMGB1 and the immune-privilege of the testis it is 
very likely that extracellular release of HMGB1 is under tight control in the testis. The 
signals triggering cytoplasmic localization and possible secretion of HMGB1 are 
unknown, but may involve pattern recognition receptors such as extracellular TLRs or 
intracellular NLRs, as well as intracellular signaling molecules including kinases. 
Future studies involving LPS treatment or cytokine treatment of in vitro cultured 
testicular cells may answer these questions. 
 
 
4.4 THE AGE DEPENDENT TESTICULAR EXPRESSION PATTERN OF 
ABC TRANSPORTERS RENDERS THE IMMATURE TESTIS MORE 
SUSCEPTIBLE TO ADVERSE ACTIONS OF XENOBIOTICS 
 
The clinically important anticancer drug Doxorubicin is a substrate for the ATP-
dependent cassette transporter proteins P-gp, Mrp1 and Bcrp. These efflux pumps are 
expressed in important tissue barriers to protect against toxicity from exogenous 
harmful agents (Ambudkar et al., 1999, Schinkel and Jonker, 2003). We used 
doxorubicin as a xenobiotic model to study the development of the ABC transporter 
dependent efflux system in the rat testis. Doxorubicin have been shown to be more 
toxic towards the reproductive system of immature rats, compared to older animals and 
to enhance apoptosis of germ cells in 6-day-old, but not in 16- and 24 day-old rats 
(Bechter et al., 1987, Hou et al., 2005). We hypothesized that this higher level of 
testicular toxicity seen in 6-day-old rats was due to the absence of ABC transporter 
expression, leading to higher uptake of doxorubicin in immature rat testes. 
 
Indeed, we found that the uptake of doxorubicin in rat testes was age-dependent. One 
hour after intra-peritoneal treatment with a single dose of 3 mg/kg doxorubicin, 6-day-
old rats and 16-day-old rats had accumulated 8-fold and 6-fold higher levels of the 
drug, compared to the testes of 24-day-old rats. The higher level of doxorubicin in the 
immature testis was not due to a higher vascular blood volume, since point counting 
revealed that the vascular space in the 6-day-old testis did not differ from that of 16- 
and 24-day-old rat testis. 
 
We therefore wanted to investigate the developmental expression of ABC-transporter 
proteins in the rat testis, to see whether a lower level of ABC transporter expression 
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could explain the higher level of doxorubicin uptake in immature testes. Real-time PCR 
analyses revealed significantly lower levels of P-gp/Mdr1a, Mrp1 and Bcrp expression 
in 6-day-old rats compared to 16- and 24 day-old rats. Similar to the testis, ABC 
transporter expression at the BBB has also been shown to limit the entrance of 
xenobiotic compounds to the brain (Schinkel et al., 1994, Schinkel et al., 1997). A 
maturational difference in P-gp/Mdr1a gene expression, analogous to that we detected 
in the rat testis, has also been observed in the mouse and rat brain (Tsai et al., 2002, 
Matsuoka et al., 1999). In addition it was shown that reduced P-gp gene expression in 
the neonatal brain, compare to the adult, resulted in greater P-gp substrate accumulation 
in the brain of the neonatal mouse (Goralski et al., 2006). This maturational difference 
in P-gp substrate accumulation was not observed in mdr1a knockout mice. 
 
Intra-peritoneal treatment with a single dose of doxorubicin did not seem to have a 
stimulatory effect on ABC transporter expression in the testis. However, we detected a 
small, but significant decrease in Mrp1 mRNA expression in 24-day-old rat testes, 4 
hours after treatment and a similar decrease in Bcrp expression in the testes of 6-day-
old rats, 24 hours after treatment. This is in contrast to other studies, where treatment 
with different MDR gene substrates has shown to stimulate MDR gene-expression 
(Chin et al., 1990, Chaudhary and Roninson, 1993, Abolhoda et al., 1999). These 
studies have been conducted on in vitro cultured cells or on tumor tissue, which may 
explain the different results, compared to our in vivo approach. 
 
In the adult rat, human, mouse and guinea pig testis, P-gp is localized to endothelial 
cells of the testicular capillaries, as well as all other somatic cell types (Melaine et al., 
2002). P-gp expression was lacking in spermatogonia, spermatocytes and early 
spermatids, but was present in late spermatids. Recently it was also shown that P-gp is 
localized to the BTB in the rat (Su et al., 2009). Since we were interested in the ABC 
transporter function in the developing testis we investigated the localization of P-gp in 
the testis from 6-, 16- and 24 day-old rats by IF. We could hardly detect P-gp 
expression in the 6-day-old testis, but in 16-day-old rats, there was prominent 
expression in Sertoli cells, endothelial cells as well as some interstitial cells. In the 24-
day-old rat testis, the tubular expression of P-gp showed a clear ring-like pattern, 
corresponding well to the location of the BTB. Our results support our hypothesis, that 
the ABC transporter efflux-pump system is not fully developed in 6-day-old rats, 
leading to a higher uptake of drug and thereby increased testicular toxicity at this young 
age, compared to older animals. 
 
P-gp has been shown to co-localize with several junctional proteins at the BTB in the 
adult rat testis (Su et al., 2009). We found co-localization of P-gp with the BTB 
proteins occludin and ZO-1, already at postnatal day 16 in the rat testis, which is the 
approximate time for when the BTB is formed. In 24-day-old rats, there was clear co-
localization of P-gp, occludin and ZO-1 at the BTB. Recently it was shown that the 
BTB localization of P-gp and its interaction with occludin, claudin-11 and JAM-A 
increased after adjudin treatment, suggesting that P-gp may decrease luminal entry of 
adjudin by increasing the tightness of the BTB (Su et al., 2009). In contrast to these 
results, we found no effect of doxorubicin treatment on the localization or intensity of 
the P-gp immunostaining at the BTB. Nor did we see an increase in P-gp co-
localization with occludin and ZO-1, suggesting that P-gp does not prevent doxorubicin 
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uptake by increasing the tightness of the BTB, seen after adjudin treatment. Rather, it is 
likely that P-gp prevents luminal entry of doxorubicin by its efflux function. 
 
There are no studies in humans, showing that treatment with doxorubicin at the pre-
pubertal age would result in a higher degree of gonadal damage compared to treatment 
after puberty. In fact, the gonadal damage caused by doxorubicin and other drugs seems 
to be less pronounced in humans, compared to rodents. One possible explanation could 
be species differences in the ontogeny of ABC transporter protein expression. 
Nevertheless, the ontogeny of ABC transporter expression in the human brain follows a 
similar pattern as in rodents, with lower ABC transporter gene expression in the 
immature brain, compared to adults (Daood et al., 2008). A study of P-gp function in 
the brain of nonhuman primates also showed a developmental difference, with higher 
uptake of P-gp substrate in the infant, compared to adult brain (Takashima et al., 2011). 
Since gonadal toxicity still is a major adverse side-effect of chemotherapeutic treatment 
of childhood cancer, characterization of the developmental expression of ABC 
transporter proteins in the human testis is of clinical importance to identify potential 
age groups which may have a higher risk for such toxicity.  
 
It is also important to understand that the combined use of drug-reversed agents 
(inhibitors of ABC transporter proteins) and chemotherapeutic drugs may increase the 
risk for side effects, including enhanced neurotoxicity (Greenberg et al., 2005, Hanko et 
al., 2003). It seems likely that such ABC transporter modulating drugs also may 
enhance the testicular toxicity associated with chemotherapy, especially in individuals 
that are at higher risk, due to immature ABC transporter function. 
 
In conclusion, we have found that testes from pre-pubertal rats (6-day-old) accumulate 
higher levels of the anticancer-drug doxorubicin compared to 16- and 24-day-old rats 
and that this increased drug-uptake correlates with a very low level of testicular ABC 
transporter proteins. During postnatal development of the rat testis, there is a gradual 
increase in ABC transporter protein expression, correlating with a reduced testicular 
uptake of doxorubicin as the rat testis matures. We suggest that lack of a mature ABC 
transporter dependent efflux system renders the immature testis more susceptible to 
xenobiotic-induced toxicity. Further studies employing ABC transporter protein 
inhibitors need to be done to confirm our results. 
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4.5 SUMMARY AND CONCLUSIONS 
The work of this thesis deals with antimicrobial and xenobiotic protection of the 
mammalian testis, focusing on the role of CAR, IL-18, HMGB1 and P-gp.  
 
 CAR is expressed in round spermatids, in late stages of elongated spermatids 
and in released spermatozoa, where it localizes to the acrosomal region. 
 
 CAR was exposed to the surface of acrosome-reacted but not acrosome-intact 
sperms, indicating a role for CAR in oocyte fertilization.  
 
 CAR co-localized and co-immunoprecipitated with JAM-C in the mouse testis, 
suggesting that CAR may function in germ cell differentiation and polarization, 
similar to JAM-C. 
 
 IL-18, IL-18R and ICE were expressed in a constitutive manner during 
postnatal testicular development in the rat, as well as in the adult rat testis.  
 
 IL-18 protein and mRNA were mainly localized to meiotic and post-meiotic 
germ cells. Only Pro-IL-18 was detected in interstitial fluid and in testicular cell 
extracts, suggesting that IL-18 normally is in its non-active form in the healthy 
testis. 
 
 IL-18 stimulated spermatogonial proliferation and thus may act as a mitogen 
during pathophysiological conditions in the testis.  
 
 HMGB1 was produced in the Sertoli cells of the human and rat testis and 
showed both nuclear and cytoplasmic localization. 
 
 HMGB1 purified from human and rat testis demonstrated potent antibacterial 
activity and may act as an antimicrobial peptide, as well as an immune-
stimulatory molecule in the testis. 
 
 Immature rats (6-day-old) accumulated more ABC transporter protein 
substrates in their testes compared to older rats (16- and 24-day-old), after in 
vivo treatment. 
 
 The higher concentration of doxorubicin in immature rat testes correlated with a 
lower level of P-gp, Mrp1 and Bcrp1 expression. 
 
 The age-dependent expression pattern of ABC transporters may render the 
immature testis more susceptible to side effects of cytotoxic drugs as well as 
other xenobiotics. 
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